Drug Discovery World

JULY 14, 2023

News round-up for 10-14 July by DDW Digital Content Editor Diana Spencer. awarded to progress ovarian cancer cell therapy NK:IO has been awarded £1.6m ($2.1m) in grant funding from Innovate UK’s New Cancer Therapeutics programme. £1m

Gene Therapy 52

Gene Therapy Life Science Drugs Gene 52

Intouch Solutions

JUNE 29, 2023

Also in … with humanity.    This year saw the highest number of AI entries, but that did not translate into a landslide of AI Lions – though there were standouts. One Pharma juror remarked: “AI is a tool to augment exceptional creative ideas, not replace them.” (We We agree.)

Branding 98

Branding 98

Drug Discovery World

JULY 17, 2023

You can listen below, or find The Drug Discovery World Podcast on Spotify , Google Play and Apple Podcasts.

Gene Therapy 52

Gene Therapy Life Science Gene Drugs 52

Drug Discovery World

JULY 17, 2023

You can listen below, or find The Drug Discovery World Podcast on Spotify , Google Play and Apple Podcasts.

Gene Therapy 52

Gene Therapy Life Science Gene Drugs 52

FDA Law Blog

JULY 10, 2023

According to the 2 nd Quarter FY2023 MDUFA V Performance Report , FDA issued a request for additional information (AI request) on the first FDA review cycle for 63% to 68% of 510(k)s submitted in FY2018 to FY2022. We will then present an effective strategy to address FDA’s AI request in a timely manner.

Packaging 75

Packaging Packaging Engineer Cosmetics 75

Drug Discovery World

AUGUST 18, 2023

News round-up for 14-18 August by DDW Digital Content Editor Diana Spencer. My chosen news stories this week all discuss pre-clinical research studies that could have a huge impact on our therapeutic approach to several hard-to-treat diseases, helping to overcome drug-resistance and make treatments more targeted in the future.

Drugs 52

Drugs Antibody Genetics Gene 52

Drug Discovery World

JANUARY 9, 2024

On Monday 5 February at 3.30pm, he will speak on ‘ Proximity-inducing drugs: using technological innovation to build the next generation of medicine. On Monday 5 February at 3.30pm, he will speak on ‘ Proximity-inducing drugs: using technological innovation to build the next generation of medicine.

Drugs 64

Drugs Protein Clinical Trials Clinical Trials 64

Drug Discovery World

MAY 26, 2023

News round-up for 22-26 May by DDW Digital Content Editor Diana Spencer. The theme of our news review this week is money. million to develop the next generation of small molecule drugs against disease areas of high clinical need.

Drugs 52

Drugs DNA RNA Manufacturing 52

Drug Discovery World

FEBRUARY 23, 2023

Kristen Hopson , Vice President of Preclinical Discovery and Development at Generate Biomedicines, and Yup Liu , Associate Director, HTS at Generate Biomedicines, reflect on the impact of AI, ML cloud computing, and advances in laboratory automation and high-throughput screening (HTS) on life science research.

Protein 52

Protein Life Science Bioassay Development 52

XTalks

MAY 16, 2023

It’s Time to Stop Faxing Medical Records In the realm of healthcare, the digitization of medical records has opened up new avenues for improving patient care and streamlining administrative processes. Artificial intelligence (AI) has emerged as a transformative force.

Doctors 97

Doctors Doctor Allergies Compliance 97

XTalks

MAY 17, 2021

An AI algorithm developed by researchers at the Mayo Clinic through its newly formed health technology company Anumana Inc. , The ECG-based AI-powered clinical decision support tool can enable diagnosis of low ejection fraction, especially in its earliest stages to facilitate more prompt diagnosis and treatment of the heart condition.

Trials 87

Trials Clinical Trials Clinical Trials Licensing 87

pharmaphorum

MARCH 7, 2022

It decodes the complex behaviour of bacteria when they are exposed to new chemical entities – known as ‘bacterial autopsies’ – according to the company. News of the cash injection came as ArrePath also announced the appointment of ex-Evotec head of anti-infectives – Dr Lloyd Payne – as its president and chief executive.

Bacteria 127

Bacteria Drugs Genome Genomics 127

pharmaphorum

FEBRUARY 24, 2022

Hong Kong-based Insilico Medicine has begun a Phase 1 trial of its AI-discovered and AI-designed anti-fibrotic small molecule inhibitor. . These platforms promise to use AI to greatly accelerate the timetable of drug discovery and development, and it’s an area investors are quite bullish on.

Trials 40

Trials Drugs Clinical Trials Clinical Trials 40

pharmaphorum

DECEMBER 16, 2022

A number of pharma-adjacent tech firms and non-profits announced personnel news in the month of November. Digital therapeutics company Cognoa, which focuses on paediatric behavioural health, announced the appointment of Dr Sharief Taraman as its new CEO. AI and robotics hires. We’ve rounded up some highlights below.

Behavioural Health 52

Behavioural Health Reagent Gene Therapy Production 52

Drug Discovery World

SEPTEMBER 28, 2022

Ben Folwell, Principal Consultant at Citeline, maps out how AI, swarm learning and open access to clinical data could revolutionise drug discovery. . Artificial intelligence (AI) is notorious for its industry hype, touted to revolutionise the way multiple sectors operate over the next five to 10 years. The simple answer is no.

Pharma Companies 52

Pharma Companies Drugs In-Vivo Genetics 52

pharmaphorum

OCTOBER 14, 2022

Glick, said the company is innovating “next generation therapeutics by marrying a powerful drug discovery engine integrating machine learning [ML], biology, and medicinal and structural chemistry with an exceptional leadership of proven drug developers”. Rowe Price Associates, Inc., Odyssey Therapeutics’ founder and CEO, Gary D.

Engineer 90

Engineer Medicine Genome Genomics 90

pharmaphorum

OCTOBER 26, 2020

MKUH will also receive a royalty on revenues generated by Sensyne from research undertaken under the SRA. The news followed Sensyne’s announcement of a new research agreement with Bristol Myers Squibb (BMS). The post NHS strikes another deal with clinical AI company Sensyne Health appeared first on.

Medicine 80

Medicine Research 80

The Pharma Data

NOVEMBER 19, 2020

AI Model May Predict Immunotherapy Response in Melanoma. A receiver operating characteristic curve was generated, and patients were stratified as high versus low risk for progression using an optimal threshold. More News Resources. Professional. THURSDAY, Nov. 19 in Clinical Cancer Research. Paul Johannet, M.D., Source link.

Medicine 52

Medicine Research Development 52

pharmaphorum

SEPTEMBER 13, 2022

Exciting news from @Verilylifesci on this $1Bn funding to further our precision health impact, including evidence generation. Exciting news from @Verilylifesci on this $1Bn funding to further our precision health impact, including evidence generation. We're set up for great things ahead!

Life Science 73

Life Science Development Clinical Trials Clinical Trials 73

XTalks

JUNE 16, 2023

Klinrisk, an artificial intelligence (AI)-based medical device company specializing in prognostic solutions for kidney disease, has been awarded an investment from the National Kidney Foundation’s Innovation Fund.

Clinical Trials 96

Clinical Trials Clinical Trials Trials Hormones 96

pharmaphorum

AUGUST 14, 2020

Catch up on the latest coronavirus vaccine and digital tech news in our roundup of this week’s biggest stories. A new digital therapy is aiming to tackle depression during the COVID-19 pandemic, using a brain stimulation headset and therapy app that claims to have similar beneficial effects to drugs but with fewer side-effects.

Vaccination 86

Vaccination Vaccine Antibody Manufacturing 86

The Pharma Data

NOVEMBER 20, 2020

As Pfizer and BioNTech announced news of a possible Covid-19 vaccine on November 8 , in haste, pharma leaders are rallying to ensure supply chains will be able to support distribution. AI Covid-19 response challenge launched to restart economies and safely reopen societies.

Drugs 52

Drugs Pharma Companies Vaccination Vaccine 52

pharmaphorum

JANUARY 31, 2022

The result was four innovative solutions for generating awareness about the importance of vaccines and improving vaccine access and administration. Medorion’s winning entry was an AI-based SaaS Health Behaviour Management platform that uses behavioural science to automate personalized conversations with patients. Generating awareness.

Vaccination 77

Vaccination Vaccine Development Marketing 77

Drug Discovery World

APRIL 8, 2024

Aviv Regev, Head and Executive Vice President of Research and Early Development at Genentech, opened the session with a discussion of how advances in genomic sequencing are fostering the development of data-rich cell atlases and what that data could mean for new insights into cancer biology and novel therapeutics.

In-Vivo 52

In-Vivo In-Vitro Antibody Protein 52

XTalks

DECEMBER 20, 2023

Xtalks compiled a list of its top life science news and trends of 2023, which provided readers with the latest developments, information and expert insights across life science industries, including pharma, biotech and medical device. Read on to see our editorial team’s top news picks of the year.

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

Pharmaceutical Technology

DECEMBER 21, 2022

Artificial intelligence (AI) continued to stay in the news with several high-profile deals this year, as the pharmaceutical industry readily took to adopting AI models to improve drug discovery. Across all sectors, AI applications are being used to increase efficiency and reduce costs. Major AI deals in 2022.

Regulation 351

Regulation Pharma Companies Medicine Clinical Trials 351

XTalks

JULY 16, 2021

In a news release , J&J said it is exercising “an abundance of caution” by pulling its Neutrogena and Aveeno spray sunscreens from shelves. Related: Google Launches AI-Based Dermatology Assist Tool. It is generated naturally by volcanoes and forest fires, and is found in crude oil.

Contamination 105

Contamination Production Drugs Branding 105

pharmaphorum

SEPTEMBER 7, 2020

Additionally, it is hard for companies to determine which initiatives they should scale up and which will add most value in the long-term, as often there is a long time before return on investment is generated. Pharma firms are awash with data, but the complexities of that data are also increasing.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Marketing 98

Drug Discovery World

NOVEMBER 22, 2023

Genentech will use NVIDEA BioNeMo to customise models at scale, and will integrate the cloud application directly into its drug discovery workflows. Initially, the companies will focus on optimising Genentech’s drug discovery AI models in its ‘lab in a loop’ framework.

Drugs 59

Drugs Life Science Development Scientist 59

Drug Discovery World

DECEMBER 21, 2023

Insilico Medicine has initiated the first-in-human study for ISM5411, a poly hydroxylase domain (PHD) 1/2 inhibitor for the treatment of inflammatory bowel disease (IBD) designed by its generative AI platform. The post AI-designed PHD 1/2 inhibitor for bowel disease enters human trials appeared first on Drug Discovery World (DDW).

Trials 52

Trials Clinical Trials Clinical Trials Medicine 52

The Pharma Data

DECEMBER 9, 2020

Below is a roundup of some of this week’s interesting news. OHMX.bio – Belgium-based OHMX.bio and Fujirebio Europe were awarded a €720,000 research grant from Flanders Innovation & Entrepreneurship (VLAIO) to develop a clinical in vitro diagnostics (IVD) platform incorporating third generation sequencing (TGS) technologies.

In-Vivo 52

In-Vivo In-Vitro Antibody Development 52

Drug Discovery World

OCTOBER 5, 2023

The webinar ‘Generative AI: Turning drug discovery into a technological pursuit’ supported by Thermo Fisher Scientific and presented by Generate:Biomedicines will be free to attend on 12 October 9am EDT / 2pm BST / 3pm CEST.

Drugs 52

Drugs Protein Medicine 52

Drug Discovery World

OCTOBER 5, 2023

Evozyne has closed an $81 million Series B investment round that will fund the biotech’s generative AI-powered drug discovery platform and product development. “In The funding follows a successful collaboration with NVIDIA earlier this year, in which the companies developed an AI model that can be used to design therapeutic proteins.

Drugs 52

Drugs Immune Response Protein Gene 52

Drug Discovery World

SEPTEMBER 26, 2023

What you will learn: How AI and ML are transforming drug discovery How generative AI can produce novel proteins How this approach can bring tailored medicines to patients Register here to attend. The post Webinar: How AI is transforming drug discovery appeared first on Drug Discovery World (DDW).

Drugs 52

Drugs Protein Medicine 52

Drug Discovery World

SEPTEMBER 18, 2023

What you will learn: How AI and ML are transforming drug discovery How generative AI can produce novel proteins How this approach can bring tailored medicines to patients Register here to attend The post Webinar: Generative AI: Turning drug discovery into a technological pursuit appeared first on Drug Discovery World (DDW).

Drugs 52

Drugs Protein Medicine 52

Drug Discovery World

MAY 4, 2023

Adaptyv Bio, a Swiss/US technology company that develops infrastructure and tools for protein designers to engineer better proteins, has built a protein engineering foundry that it says will “pave the way” for protein designers to develop new medicines, novel enzymes and sustainable materials.

Engineer 52

Engineer Protein Life Science Medicine 52

Pharma Marketing Network

NOVEMBER 4, 2020

Tom (AC): Yeah so we have a two products one is a self-service to what we were searching audience generate the ads from scratch. RJ (PMN): That’s a great customer base in across multiple industries which is exciting cause it gives you a lot of views into what everyone else is doing. RJ (PMN): Interesting.

Branding 52

Branding Marketing Regulation Production 52